Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: The Victorian Transperineal Biopsy Collaboration experience

BJU International

Volumn 116, Issue 4, 2015, Pages 568-576

  Ong, Wee Loon ^a   Weerakoon, Mahesha ^a   Huang, Sean ^a   Paul, Eldho ^a   Lawrentschuk, Nathan ^a,b   Frydenberg, Mark ^a   Moon, Daniel ^a   Murphy, Declan ^a   Grummet, Jeremy ^a  

^a MONASH UNIVERSITY   (Australia)

^b AUSTIN HOSPITAL   (Australia)

Author keywords

prostate biopsy; prostate cancer; transperineal; TRUS

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSESSMENT; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; REPEAT PROCEDURE; TRANSPERINEAL BIOPSY; TRANSRECTAL ULTRASOUND GUIDED BIOPSY; ECHOGRAPHY; IMAGE GUIDED BIOPSY; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; HUMANS; IMAGE-GUIDED BIOPSY; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84941168146     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13031     Document Type: Article

References (52)

1. Hodge KK, McNeal JE, Terris MK, Stamey TA,. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71-4
2. Stewart CS, Leibovich BC, Weaver AL, Lieber MM,. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166: 86-91
3. Scattoni V, Zlotta A, Montironi R, Schulman C, Rigatti P, Montorsi F,. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 2007; 52: 1309-22
4. USANZ. Prostate Biopsy Audit Report. Urological Society of Australia and New Zealand, 2005
5. USANZ. Prostate Biopsy Audit Report. Urological Society of Australia and New Zealand, 2007
6. Chang DT, Challacombe B, Lawrentschuk N,. Transperineal biopsy of the prostate-is this the future? Nat Rev Urol 2013; 10: 690-702
7. Grummet J, Weerakoon M, Huang S, et al. Sepsis and superbugs: should we favour the transperineal over the transrectal approach for prostate biopsy. BJU Int 2014; 114: 384-8
8. Hossack T, Patel MI, Huo A, et al. Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol 2012; 188: 781-5
9. Kuru TH, Wadhwa K, Chang RT, et al. Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics. BJU Int 2013; 112: 568-77
10. Epstein JI, Sanderson H, Carter HB, Scharfstein DO,. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology 2005; 66: 356-60
11. Emiliozzi P, Longhi S, Scarpone P, Pansadoro A, DePaula F, Pansadoro V,. The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen. J Urol 2001; 166: 845-50
12. Furuno T, Demura T, Kaneta T, et al. Difference of cancer core distribution between first and repeat biopsy: in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. Prostate 2004; 58: 76-81
13. Vyas L, Acher P, Challacombe B, et al. Indications, results and safety profile of transperineal sector biopsies of the prostate: a single centre experience of 634 cases. BJU Int 2014; 114: 32-7
14. Kojima M, Hayakawa T, Saito T, Mitsuya H, Hayase Y,. Transperineal 12-core systematic biopsy in the detection of prostate cancer. Int J Urol 2001; 8: 301-7
15. Emiliozzi P, Scarpone P, DePaula F, et al. The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/mL: a randomized study of 6 versus 12 core transperineal prostate biopsy. J Urol 2004; 171: 197-9
16. Yamamoto S, Kin U, Nakamura K, et al. Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5-20 ng/mL in Japan. Int J Clin Oncol 2005; 10: 117-21
17. Demura T, Hioka T, Furuno T, et al. Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy. Cancer 2005; 103: 1826-32
18. Ficarra V, Novella G, Novara G, et al., The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy. Eur Urol 2005; 48: 932-7
19. Luciani LG, De Giorgi G, Valotto C, Zanin M, Bierti S, Zattoni F,. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings. Urology 2006; 67: 555-8
20. Li H, Yan W, Zhou Y, Ji Z, Chen J,. Transperineal ultrasound-guided saturation biopsies using 11-region template of prostate: report of 303 cases. Urology 2007; 70: 1157-61
21. Hara R, Jo Y, Fujii T, et al., Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology 2008; 71: 191-5
22. Takenaka A, Hara R, Ishimura T, et al. A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy. Prostate Cancer Prostatic Dis 2008; 11: 134-8
23. Suzuki M, Kawakami S, Asano T, et al. Safety of transperineal 14-core systematic prostate biopsy in diabetic men. Int J Urol 2009; 16: 930-5
24. Taira AV, Merrick GS, Galbreath RW, et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis 2010; 13: 71-7
25. Numao N, Kawakami S, Sakura M, et al. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU Int 2012; 109: 665-71
26. Symons JL, Huo A, Yuen CL, et al. Outcomes of transperineal template-guided prostate biopsy in 409 patients. BJU Int 2013; 112: 585-93
27. Pepe P, Aragona F,. Prostate biopsy: results and advantages of the transperineal approach-twenty-year experience of a single center. World J Urol 2013; 32: 373-7
28. Kuru TH, Roethke MC, Seidenader J, et al. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 2013; 190: 1380-6
29. Igel TC, Knight MK, Young PR, et al. Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk. J Urol 2001; 165: 1575-9
30. Satoh T, Matsumoto K, Fujita T, et al. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology 2005; 66: 114-8
31. Pinkstaff DM, Igel TC, Petrou SP, Broderick GA, Wehle MJ, Young PR,. Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. Urology 2005; 65: 735-9
32. Bott SR, Henderson A, Halls JE, Montgomery BS, Laing R, Langley SE,. Extensive transperineal template biopsies of prostate: modified technique and results. Urology 2006; 68: 1037-41
33. Moran BJ, Braccioforte MH, Conterato DJ,. Re-biopsy of the prostate using a stereotactic transperineal technique. J Urol 2006; 176: 1376-81; discussion 81.
34. Kawakami S, Yamamoto S, Numao N, Ishikawa Y, Kihara K, Fukui I,. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int J Urol 2007; 14: 719-24
35. Moran BJ, Braccioforte MH,. Stereotactic transperineal prostate biopsy. Urology 2009; 73: 386-8
36. Novara G, Boscolo-Berto R, Lamon C, et al. Detection rate and factors predictive the presence of prostate cancer in patients undergoing ultrasonography-guided transperineal saturation biopsies of the prostate. BJU Int 2010; 105: 1242-6
37. Dimmen M, Vlatkovic L, Hole KH, Nesland JM, Brennhovd B, Axcrona K,. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int 2012; 110 (2 Pt 2): E69-75
38. Pal RP, Elmussareh M, Chanawani M, Khan MA,. The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies. BJU Int 2012; 109: 367-71
39. Mabjeesh NJ, Lidawi G, Chen J, German L, Matzkin H,. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int 2012; 110: 993-7
40. Bittner N, Merrick GS, Butler WM, Bennett A, Galbreath RW,. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy. J Urol 2013; 190: 509-14
41. Ekwueme K, Simpson H, Zakhour H, Parr NJ,. Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy. BJU Int 2013; 111: E365-73
42. Gershman B, Zietman AL, Feldman AS, McDougal WS,. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol Oncol 2013; 31: 1093-7
43. Ahmed HU, Hu Y, Carter T, et al. Characterizing clinically significant prostate cancer using template prostate mapping biopsy. J Urol 2011; 186: 458-64
44. Acher P, Dooldeniya M,. Prostate biopsy: will transperineal replace transrectal? BJU Int 2013; 112: 533-4
45. Bostwick DG, Waters DJ, Farley ER, et al. Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. Urology 2007; 70 (Suppl.): 42-4
46. Bott SR, Young MP, Kellett MJ, Parkinson MC,. Contributors to the UCLHTRPD. Anterior prostate cancer: is it more difficult to diagnose? BJU Int 2002; 89: 886-9
47. Lawrentschuk N, Haider MA, Daljeet N, et al. 'Prostatic evasive anterior tumours': the role of magnetic resonance imaging. BJU Int 2010; 105: 1231-6
48. Thompson J, Lawrentschuk N, Frydenberg M, Thompson L, Stricker P,. Usanz. The role of magnetic resonance imaging in the diagnosis and management of prostate cancer. BJU Int 2013; 112 (Suppl. 2): 6-20
49. Ashley RA, Inman BA, Routh JC, et al. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol 2008; 53: 976-81
50. Campos-Fernandes JL, Bastien L, Nicolaiew N, et al., Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur Urol 2009; 55: 600-6
51. Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED Jr,. The influence of prostate size on cancer detection. Urology 1995; 46: 831-6
52. Merrick GS, Gutman S, Andreini H, et al. Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. Eur Urol 2007; 52: 715-23